Somerville Kurt F acquired a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 15,539 shares of the company’s stock, valued at approximately $1,997,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Frazier Financial Advisors LLC purchased a new position in shares of Merck KGaA in the second quarter worth about $25,000. Addison Advisors LLC bought a new stake in shares of Merck KGaA in the second quarter valued at approximately $90,000. Comprehensive Financial Planning Inc. PA purchased a new stake in shares of Merck KGaA during the 2nd quarter valued at approximately $134,000. Stevens Capital Partners purchased a new stake in shares of Merck KGaA during the 2nd quarter valued at approximately $220,000. Finally, United Bank bought a new position in Merck KGaA in the 2nd quarter worth approximately $248,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Stock Up 4.5%
Merck KGaA stock opened at $167.38 on Thursday. Merck KGaA has a 1-year low of $116.68 and a 1-year high of $175.56. The firm has a market capitalization of $21.63 billion, a price-to-earnings ratio of 25.55 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The firm has a 50 day simple moving average of $162.50 and a 200 day simple moving average of $148.28.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
